Clinical Trials in Delaware
Delaware ranks #38 nationally by clinical-trial count, with 38 trials listed, all currently recruiting.
Among trials with a recorded phase, Phase 3 is the largest group at 10 trials.
The top conditions by trial volume are Sickle Cell Disease (3), Hemophilia (2), Homozygous Familial Hypercholesterolemia (1).
38
Total Trials
38
Recruiting
#38
National Rank
5
Conditions
Trials by Phase
17
Not Applicable
1
Phase 1 / Phase 2
1
Phase 2 / Phase 3
1
Phase 1
7
Phase 2
10
Phase 3
1
Phase 4
Top Conditions in Delaware
| # | Condition | Trials |
|---|---|---|
| 1 | Sickle Cell Disease | 3 |
| 2 | Hemophilia | 2 |
| 3 | Metabolic Disorders | 1 |
| 4 | Septic Shock | 1 |
| 5 | Cancer | 1 |
Top Sponsors in Delaware
Cities With Most Trials in Delaware
| # | City | Trials |
|---|---|---|
| 1 | Wilmington | 24 |
| 2 | Newark | 20 |
| 3 | Millville | 3 |
| 4 | Rehoboth Beach | 2 |
| 5 | Lewes | 2 |
Important: This information is for research purposes only. Always talk to your doctor about whether a clinical trial is right for you.
Frequently Asked Questions
Delaware currently has 38 clinical trials actively recruiting participants, making it #38 nationally by total trial count.
The most-studied conditions in Delaware are Sickle Cell Disease (3 trials), Hemophilia (2 trials), Metabolic Disorders (1 trials).
Browse the conditions listed on this page to find trials recruiting in Delaware. Each condition page shows trial details, eligibility criteria in plain English, and contact information. Always talk to your doctor about whether a trial is right for you.
Trial counts reflect currently recruiting studies listed on ClinicalTrials.gov with locations in this state.
Source: ClinicalTrials.gov, 2026.